title: Who and when should we screen for prostate cancer? Interviews with key opinion leaders.
abstract: Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening.
authors.affiliation: Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, 10017, NY, USA. carlssos@mskcc.org
authors.forename: Sigrid
authors.initials: S
authors.lastname: Carlsson
authors.affiliation: Department of Urology, University of California, San Francisco, CA, USA. michael.leapman@ucsf.edu.
authors.forename: Michael
authors.initials: M
authors.lastname: Leapman
authors.affiliation: Department of Urology, University of California, San Francisco, CA, USA. peter.carroll@ucsf.edu.
authors.forename: Peter
authors.initials: P
authors.lastname: Carroll
authors.affiliation: Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. secr.schroder@erasmusmc.nl.
authors.forename: Fritz
authors.initials: F
authors.lastname: Schröder
authors.affiliation: University of Connecticut Health Center, 263 Farmington Avenue, Farmington, 06030, CT, USA. albertsen@uchc.edu.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Albertsen
authors.affiliation: Department of Epidemiology & Preventive Medicine, Monash University, Level 6, The Alfred Centre, 99 Commercial Rd, Melbourne, VIC, 3004, Australia. dragan.ilic@monash.edu.
authors.forename: Dragan
authors.initials: D
authors.lastname: Ilic
authors.affiliation: The Informed Medical Decisions Foundation, Boston, MA, USA. dominick.frosch@moore.org.
authors.forename: Michael
authors.initials: M
authors.lastname: Barry
authors.affiliation: Gordon and Betty Moore Foundation, Palo Alto, CA & Department of Medicine, University of California, Los Angeles, USA. mbarry@healthwise.org.
authors.forename: Dominick L
authors.initials: DL
authors.lastname: Frosch
authors.affiliation: Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, New York, 10017, NY, USA. vickersa@mskcc.org.
authors.forename: Andrew
authors.initials: A
authors.lastname: Vickers
mesh_terms: D000368:Aged; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000175:diagnosis*
chemical_list: D017430:Prostate-Specific Antigen